SHUKFINANCEAnalysis
FRShukFinance
Epitomee Medical
Company page · Medical devices

Epitomee Medical

TASE : EPITISIN : IL0011825911Headquarters: CaesareaIFRS accounts · in $M

Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. Based in Caesarea.

Price₪2.66−4.3% · session of 12/11/2026
Market cap₪81Mprice × number of shares
Next resultsno later than 30/11/2026Quarterly report
1-year price−56.4% over the period
Analysis in brief · H1 2026

Epitomee Medical: net income sharply down (−35.3%), cash flow down (−12.4%), operating income stable (−1.5%).

  • Net income sharply down

    Net income: $−5M, vs. $−4M a year earlier, i.e. −35.3%.

    H1 2026
  • Cash flow down

    Operating cash flow: $−4M, vs. $−4M a year earlier, i.e. −12.4%.

    H1 2026
  • Operating income stable

    Operating income: $−5M, vs. $−5M a year earlier, i.e. −1.5%.

    H1 2026
Built automatically from the published figures.
Valuation

What the market pays, vs. the sector

P/En.s.12-month loss
P/B1.2market cap / equity
Dividend yield0%dividends over the last 12 months / price
12-month range₪2.22 – ₪9.27monthly closes

This company's valuation multiples history is being built day by day from now on.

P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.

Insiders

Trades by executives and interested parties

13 filing(s) over 12 months · on shares: 3 increase(s) and 10 decrease(s) in holdings.

DateHolderSecurityDirectionQuantityPrice
05/11/2026Dolev Rafaeli
Director		SharesUp1,801,213—Maya ›
22/09/2026Moran Tabak
Executive		SharesUp550,594—Maya ›
11/06/2026Josefa Landskroner
Executive		SharesDown5,000—Maya ›
12/05/2026Yael Kenan
Executive		SharesDown2,500—Maya ›
07/05/2026Yael Kenan
Executive		SharesDown5,2510.22Maya ›
26/04/2026Josefa Landskroner
Executive		SharesDown2,737—Maya ›
23/04/2026Josefa Landskroner
Executive		SharesDown6,518—Maya ›
14/04/2026Gil Cohen
Executive		SharesDown8,122—Maya ›
09/04/2026Gil Cohen
Executive		SharesDown1,878—Maya ›
29/03/2026Gil Cohen
Executive		SharesDown10,000—Maya ›
25/03/2026Hadas Stepler
Executive		SharesUp70,000—Maya ›
01/01/2026Eti Ganon Elazar
Executive		SharesDown4,000—Maya ›

Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.

Follow earnings · WhatsApp group TA-125Details ▾
WhatsApp group · TA-125

Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.

Detailed figures and history
The figures

Financial summary

S1 2026S1 2025FY 2025
Total assets293733
Current assets101914
Non-current assets191819
Equity213126
of which minority interests000
Current liabilities322
Non-current liabilities545
Revenue100
Gross profit−10−1
Operating income−5−5−10
Pre-tax income−5−4−9
Net income−5−4−9
Net income (attributable to shareholders)−5−4−9
Dividends paid000
Operating cash flow−4−4−8

In millions of dollars. The "H1" columns cover the first six months of the year.

Ratios

Calculated from these figures

S1 2026S1 2025FY 2025
Gross margin−108.0%—−307.0%
Operating margin−814.5%—−4,475.1%
Net margin−856.3%—−4,043.2%
Current ratio (current assets / current liabilities)3,9 x7,7 x6,2 x
Equity / total assets73.6%82.9%78.4%

The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.

Company overview

Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.

Source: official company profile (Yahoo Finance), summary. Website: epitomeemedical.com

Sources

No dividend paid over the past five years (source: Yahoo Finance).

Information, no recommendation. This site presents figures published by companies and calculations based on those figures. It is not investment advice, nor a recommendation to buy or sell, nor a valuation of the companies. Always check the original reports.